SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 373 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $378,813 | +6.6% | 3,125 | -4.6% | 0.18% | +6.0% |
| Q2 2023 | $355,338 | -21.0% | 3,275 | +0.4% | 0.17% | -24.8% |
| Q1 2023 | $449,739 | +13.6% | 3,263 | +6.8% | 0.22% | +8.3% |
| Q4 2022 | $395,867 | +17.1% | 3,055 | 0.0% | 0.20% | +6.2% |
| Q3 2022 | $338,000 | +32.5% | 3,055 | -10.4% | 0.19% | +38.8% |
| Q2 2022 | $255,000 | -4.1% | 3,408 | +0.1% | 0.14% | +8.6% |
| Q1 2022 | $266,000 | -13.4% | 3,405 | 0.0% | 0.13% | -5.2% |
| Q4 2021 | $307,000 | -2.5% | 3,405 | 0.0% | 0.14% | -5.6% |
| Q3 2021 | $315,000 | -6.2% | 3,405 | -21.3% | 0.14% | +3.6% |
| Q2 2021 | $336,000 | -54.0% | 4,325 | +0.8% | 0.14% | -61.3% |
| Q4 2020 | $731,000 | +14.6% | 4,290 | -5.5% | 0.36% | -8.7% |
| Q3 2020 | $638,000 | +4.4% | 4,540 | +19.2% | 0.39% | -8.9% |
| Q2 2020 | $611,000 | +34.3% | 3,810 | -18.2% | 0.43% | +3.6% |
| Q1 2020 | $455,000 | -56.1% | 4,655 | -42.1% | 0.41% | -47.1% |
| Q4 2019 | $1,037,000 | – | 8,035 | – | 0.78% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |